Why do palpitations happen during GLP-1 dose increases
This helps reduce pressure on the stomach, making the symptoms less aggressive
A recent trial comparing tirzepatide to semaglutide showed a greater increase in weight loss after a year, with losses of 15.3% with tirzepatide compared with 8.3% for semaglutide
Specific benefits for people with high blood pressure include: Weight reduction : Weight loss varies by agent and dosemore substantial with higher doses of semaglutide (Wegovy) for obesity management, and more modest with standard diabetes doses of GLP-1 agonists Reduced arterial stiffness : Some studies suggest GLP-1 agonists may improve vascular function Kidney effects : Some GLP-1 agonists have shown benefits in reducing albuminuria and slowing kidney disease progression, though SGLT2 inhibitors are generally preferred for kidney protection in diabetes [10] [19] Reduced cardiovascular events : The overall reduction in heart attacks and strokes benefits people with hypertension However, it is important to understand the potential risks and side effects
Emerging roles include treating non-alcoholic fatty liver disease, preeclampsia, and neurodegenerative diseases like Alzheimers, due to anti-inflammatory and neuroprotective effects
Because compounded semaglutide is not an FDA-approved product and therefore sits outside standard formularies